Aamir Khan and Zaira Wasim’s Secret Superstar continued set new benchmarks at the Chinese box office. The musical drama showed substantial growth on today and has crossed the 400 crore mark. It now stands with the grand total of Rs 418 crore. In fact, today Secret Superstar reclaimed the no. 1 position from Maze Runner: The Death Cure. The film is expected to achieve the Rs 500 crore benchmark by this week.
#SecretSuperstarInChina has crossed ₹ 400 Cr Mark..
After the 2nd weekend, it has grossed US$ 65.72 Million [₹ 418 Crs] in #China
Reclaimed No.1 spot on Sunday from #MazeRunnerTheDeathCure
— Ramesh Bala (@rameshlaus) January 28, 2018
With the humongous success of Secret Superstar, Aamir Khan continues to rule over the Chinese box office like his previous films like Dangal and PK. In fact, Secret Superstar had crushed the lifetime business of PK in just three days in the China market. The story of Secret Superstar revolves around a girl from a Muslim conservative family named Insia Malik, who dreams to become a popular singer. (Also Read: Box office report: Ranveer Singh’s Padmaavat has already become bigger than Prabhas’ Baahubali 2 and Aamir Khan’s Dangal; here’s how)
Directed by Advait Chandan, the film also stars Meher Vij and Raj Arjun in key roles. Apart from enjoying a successful in the domestic market, Secret Superstar also won three Filmfare awards in the category of Best supporting actress (Meher Vij), Best actress critics (Zaira Wasim) and Best singer (Meghna Mishra). Salman Khan’s 2015 blockbuster Bajrangi Bhaijaan is also slated to release on March 2 in China as Little Lolita Monkey God Uncle. With 8000 screens, we hope the Salman Khan and Kareena Kapoor Khan starrer follows the success of Aamir Khan’s films in this market. Coming back to Secret Superstar, do you think it will beat Dangal’s lifetime collections at the Chinese box office? Share your thoughts in the comment section below
This post first appeared on Bollywood News And Gossip | Bollywood Movie Review, please read the originial post: here
